Bortezomib use in chronic antibody-mediated allograft dysfunction: a report of three cases. | Colorado PROFILES

Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)

Menu

History

Calreticulin

Immunotoxin therapy of

Cytidine Diphosphate

Heavy Metal Poisoning,

Bortezomib use in chro

See All (20) pages

Contact Us
If you have any questions or feedback please contact us.

Bortezomib use in chronic antibody-mediated allograft dysfunction: a report of three cases.

Cooper JE, Wiseman AC, Chan L. Bortezomib use in chronic antibody-mediated allograft dysfunction: a report of three cases. Clin Transpl. 2009; 455-9.

View in: PubMed

subject areas

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)